Latest News for RBGLY
Reckitt (RBGLY) is pushing deeper into a focused brand strategy as Chief Executive Officer Kris Licht continues a multiyear turnaround aimed at simplifying the
Reckitt Benckiser Group plc (RBGLY) Q4 2025 Earnings Call Transcript
Consumer health group delivers core growth ahead of medium-term guidance as emerging markets surge and Essential Home disposal completes Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, XETRA:3RB), the maker of Dettol, Nurofen and Durex, said it looks forward "with confidence" after a year in which its core business grew faster than its own medium-term targets, and promised to sustain that momentum into 2026. The…
The Lysol disinfectant maker's sales grew 5% on a like-for-like basis on year, Reckitt Benckiser said.
Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totaling 262,261 shares, an increase of 47.2% from the December 31st total of 178,121 shares. Currently, 0.0% of the shares of the stock are sold short.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for RBGLY.
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for RBGLY.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.